本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
SEOUL, South Korea, Jan. 10, 2025 /PRNewswire/ -- SN BioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a Phase 1b/2 clinical trial. This achievement follows the designation of SNB-101 as an orphan drug for small cell lung cancer in 2023 and its Fast Track designation in 2024. With this latest clearance, SNB-101 is rapidly advancing toward early commercialization in the U.S. market. SN BioScience expects to initiate the clinical trials in Q2, 2025. SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA Validated for ES-SCLC, SNB-101 Eyes 2028 U.S. Market LaunchSN BioScience has revealed details of its Phase 1b/2 clinical trial for SNB-101, targeting patients diagnosed with Extensive Stage Small Cell Lung Cancer (ES-SCLC). The trial will concentrate on dose escalation and optimization to improve both efficacy and safety. Approximately 55 patients will be enrolled, with a focus on reflecting the racial diversity of the U.S. population. Furthermore, the study, aimed at supporting Phase 2 clearance in Europe, will be conducted across South Korea, the U.S., and Europe. Efficacy, safety, and pharmacokinetics will serve as the primary endpoints. Following the dose optimization phase, the company plans to assess SNB-101's efficacy and safety in approximately 100 patients through a single-arm, single-dose, open-label monotherapy study. If the results are positive, SN BioScience targets early U.S. commercialization, with market entry expected as early as 2028. Small cell lung cancer (SCLC), representing 12-15% of all lung cancer cases, is an aggressive disease with a poor prognosis. Around 70% of patients are diagnosed at an extensive stage, where the cancer has already spread, resulting in a five-year survival rate of less than 7%. Despite these challenging statistics, the SCLC treatment market is expected to grow at a compound annual growth rate (CAGR) of 7-10% from 2023 to 2030, according to Evaluate Pharma, highlighting the urgent need for more effective therapies. In this context, SNB-101 emerges as a highly promising treatment option, offering the potential to significantly improve patient outcomes. SN BioScience aims to establish its treatment as a second- or third-line option for patients resistant to existing therapies. Ultimately, the company seeks to position the therapy as a first- or second-line standard treatment, potentially in combination with immuno-oncology agents. About SN BioScience Inc. Founded in May 2017, SN BioScience is a biotech company specializing in drug delivery systems for cancer therapies. Based in the 2nd Pangyo Techno Valley in Seongnam-si, Gyeonggi-do, Korea, the company was established by experts in pharmaceutical R&D, world-class bio-polymer researchers, and clinical professionals. Since its inception, SN BioScience has focused on the commercialization of innovative technologies, particularly in the development of nanoliposomes and nanoparticle drug carriers, supported by advanced pharmacometrics and pharmacokinetics. SNB-101 SNB-101 is an innovative anticancer drug, marking the world's first nanoparticle formulation of SN-38, the active metabolite of irinotecan. Utilizing SN BioScience's dual nano-micelle delivery system, SNB-101 overcomes the drug resistance and safety issues seen with traditional treatments. The drug has already been highlighted for its use in drug-antibody conjugates (ADCs) such as Enhertu® and Trodelvy®. Preclinical studies suggest that SNB-101 may also be effective against lung, pancreatic, and stomach cancers, expanding its potential applications in oncology.
HANGZHOU, China, Jan. 9, 2025 /PRNewswire/ -- Hengdian Group Capital (HgC) and Apeloa Pharmaceutical (subsidiaries of Hengdian Group) will attend the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco from January 13-16, 2025. HgC CEO Gary Xu and Apeloa VP George Cai will be present along with their teams to connect with industry leaders, explore new opportunities and advance their shared mission of driving healthcare innovation. Please contact HgC at patrick@hgcfunds.com or Apeloa at mark.xu@apeloa.com to set up meetings. About HgC and Apeloa HgC is the investment and corporate development arm of Hengdian Group, one of the largest family-owned conglomerates in China. With over $350 million USD in assets under management, HgC's sector focus spans Smart Manufacturing & Renewables, Biotech & Medtech, and Film & Consumer. As part of the Group's globalization strategy, HgC seeks to invest, acquire, and/or license-in companies or products that provide synergistic value to the Group or deliver strong growth potential to its portfolio. HgC's recent notable investments: Zelgen Pharmaceuticals (SHSE: 688266) Weihua New Material (SHSE: 603310) Corxel Pharmaceuticals Atomwise Apeloa (www.apeloa.com), part of Hengdian Group, is a top five pharmaceutical CDMO in China. It has been engaged in CDMO for over 20 years with currently eight manufacturing sites and over 2000 employees. Its R&D centers are located in Boston, Shanghai and Hengdian. Its R&D capabilities include flow chemistry, synthetic biology & biocatalysis, highly potent compound, crystallization & particle engineering, TPD/PROTAC, and peptide. Apeloa has the largest manufacturing capacity among the top five CDMOs in China and has been inspected by the US FDA 18 times since 2006. Apeloa's key milestones in 2024: Inaugurated new CDMO R&D Center in the US in Greater Boston focusing on preclinical route scouting, scale-up production, and platform development for PROTAC, ADC and peptide synthesis Celebrated the company's 35th anniversary with a grand gala titled "Together, Towards Tomorrow" at the Palazzo Reale in Milan Gained FDA approval for Amantadine Hydrochloride tablets, an antidyskinetic medicine used to treat Parkinson's disease and symptoms Gained FDA approval for Metoprolol Succinate extended-release tablets, used to treat hypertension, angina and chronic heart failure Launched API product Gabapentin, an epilepsy medication, produced more sustainably and with reduced environmental impact; CEP submitted Contact: Mark Xu, mark.xu@apeloa.com +86 1575 711 5848 (Media)Patrick Pan, patrick@hgcfunds.com +86 1362 571 2127 (Investors)
LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- TCL, a leading global technology company, marks its 31st consecutive year at CES with an impressive 2,342-square-meter exhibition space. Ranking second globally for TV shipments and in North America for TV retail sales volume during the first three quarters of 2024, TCL have earned widespread consumer recognition in local market. The expansive booth showcases TCL's comprehensive product portfolio, from the world's largest 115-inch QD-Mini LED TV to innovative smart home appliances, alongside groundbreaking display technologies from TCL CSOT. The exhibition space also features dedicated zones for TCLArt and TCLGreen initiatives, demonstrating TCL's vision of technology enhancing everyday life through its brand philosophy of "Inspire Greatness." INSPIRE GREATNESS TCL@CES 2025 LAS VEGAS At the entrance, visitors are greeted by a spectacular giant TV robot constructed from various TCL television models, creating a striking visual representation of the company's technological prowess. The centerpiece of TCL's TV lineup is the world's largest QD-Mini LED TV, the 115'' QM891G. Along with Q85 Soundbar, it is showcased as the perfect companion for large TVs with immersive audio performance. TCL's innovative product lineup extends beyond displays. The award-winning NXTPAPER 4.0 technology, an evolution of the brand's full-color electronic paper display technology, debuts in the TCL NXTPAPER 11 Plus Tablet, with plans to expand to mobile phones. The company also introduces TCL Ai Me, the world's first modular AI companion robot, featuring a charming lifelike aesthetic and a detachable space capsule base that seamlessly blends companionship with smart living. In home appliances, the TCL FreshIN 3.0 Air Conditioner redefines cooling with its liftable Fresh Air Inlet and smart voice control capabilities. The TCL FREE BUILT-IN Refrigerator transforms modern kitchens with its sleek design and cutting-edge food preservation technologies, while the P680 Washer-Dryer Set offers stackable solutions with anti-wrinkle technology for optimal garment care. TCL CSOT, the company's display technology arm, demonstrates its comprehensive innovation capabilities across multiple technology breakthroughs. Under its APEX technology brand that focuses on Amazing – Pleasant Display Experience, Protective – Reliable Vision Health, Eco-friendly Sustainable Green and Low Carbon and unlimited future imagination (X), the company showcases its First Mass-Produced 4K IJP OLED Professional Display (21.6"). In the automotive sector, TCL CSOT unveils cutting-edge smart cockpit solutions including the Brightest Micro LED Panoramic HUD (10.25"), alongside innovative solutions like the Curved Wood-Infused Display (Dual 23.6") with ultra-narrow 1mm gap, demonstrating its leadership in next-generation display technology. The exhibition space seamlessly integrates TCL's brand initiatives - TCLArt and TCLGreen - with cutting-edge technology, creating an immersive experience that reflects TCL's commitment to combining technology with humanistic values. These initiatives underscore TCL's brand strategy of "Be Global, Be Caring, Be Tech," which guides the company's approach to product development and market engagement. The TCLArt zone features the "Light and Shadow" installation, where TCL's A300 Series TVs with advanced AG POL technology display masterpieces from the 19th and early 20th centuries, while offering AI-powered art creation capabilities. In the TCLGreen zone, an award-winning sculpture crafted from over 1,000 upcycled circuit boards demonstrates TCL's environmental commitment, which is further validated by the company's improved sustainability performance score in S&P Global's Corporate Sustainability Assessment (CSA), achieving 39 points in 2024 with a 29% rise in industry ranking. INSPIRE GREATNESS TCL@CES 2025 LAS VEGAS In the innovation zone, RayNeo introduces its latest AR glasses, the RayNeo X3 Pro Smart Glasses, which marks the arrival of the true AR era. With built-in computing power, the model eliminates the need for external devices, delivering enhanced performance in a compact, streamlined design. About TCL TCL, an acronym for "The Creative Life", encapsulates the essence of creativity as it permeates every facet of our lives. Creativity blossoms in an environment of empowerment. It is the vital force that inspires the smallest and biggest aspects of life. TCL always puts people first, using technology to drive creativity, to transform the world, and to empower lives.
LAS VEGAS, Jan. 8, 2025 /PRNewswire/ -- January 7–10, the highly anticipated CES 2025, the world's largest consumer electronics show, kicked off in Las Vegas, USA. On this global stage showcasing top-tier tech products, the home robotics brand SenseRobot made a spectacular debut with its range of products, including the SenseRobot Chess, SenseRobot 2-in-One , SenseRobot Go, SenseRobot 4-in-One, and the Light Wing Lamp. Among them, the "SenseRobot Chess and SenseRobot 2-in-1" made its global debut at CES 2025, wowing the audience as a representative of innovative AI products and announcing the start of the pre-launch phase. Entering the SenseRobot booth at CES 2025, the crowd is buzzing with excitement. Rows of minimalist, cool, and tech-inspired SenseRobots are neatly displayed, attracting visitors from all over the world to stop and play. AI-Powered Chess Fun: the pioneer of home chess robot SenseRobot brings chess to life with cutting-edge AI vision technology and intelligent decision-making algorithms. Its home-use robotic arm, designed with millimeter-level precision, effortlessly performs tasks like picking up chess pieces, enabling human vs. AI games, human vs. human games, and recording and reviewing gameplay. It's the world's first company to mass-produce household Al roboticarm robots on a large scale, more than 100,000 units have been shipped. More than a robot, SenseRobot transforms learning into an adventure. Its tri-sensory interactive experience-makes chess exciting and engaging for kids, sparking curiosity and a love for the game. For chess enthusiasts, it's a professional-level training partner, helping to sharpen skills while adding a touch of intelligent fun to every match. With the Apex Duel mode, you can challenge the top chess Al with a rating of ELO3200 and enjoy the thrill of playing chess. SenseRobot Chess It combines traditional 3D chess pieces and innovatively designed three-finger mechanical claws for flexible grasping of chess pieces. Equipped with an advanced visual algorithm, SenseRobot accurately detects and recognizes chess pieces, even in challenging conditions. You can play on a physical board, improve with 25 coaching levels, and compete online with players worldwide. From beginner lessons to grandmaster strategies, it's the perfect coach and partner for chess enthusiasts. SenseRobot 2-in-One It supports chess and draughts, with 25 levels of chess AI built in and 10 levels of draughts AI. It is equipped with teaching courses customized with leading institutions, using human-like teaching methods to enhance interest in learning chess. It's fun for the whole family with the functions of chess level-breaking, apex duel, exercise & training, classic game review, online chess, endgame challenge, etc. Our SenseRobot Chess and SenseRobot 2-in-One will be launching on Kickstarter soon! Visit our PreLaunch page for detailed information and to get exclusive early bird pricing. https://prelaunch.com/projects/senserobot-senserobot-ai-powered-smart-chess-coach-and-companion About Us As a pioneer in the home chess robot industry, SenseRobot is redefining the future of home intelligence through groundbreaking AI innovation. As the world's first company to achieve large-scale production of home-use AI robotic arms, we're setting a new standard in intelligent living—bringing the art of chess and the power of technology to everyday life. Rooted in our core philosophy of "innovation and companionship," SenseRobot transforms cold technology into warm, engaging experiences. Our robots are more than just chess masters—they're family companions, sparking joy, fostering learning, and creating meaningful moments of connection. We are relentless in our pursuit of innovation, driving the global adoption of AI-powered solutions. With every move, we aim to bring families closer, making life smarter, more joyful, and full of infinite possibilities. For business inquiries, please contact cooperation@senserobotchess.com
PHNOM PENH, CAMBODIA - Media OutReach Newswire - 8 January 2025 - Prince Foundation welcomed 10 Nanyang Technological University (NTU) students from Singapore for a three-week program focused on expanding education access and entrepreneurship mentoring in Cambodia. NTU students return to Cambodia to develop innovative solutions for advancing education and entrepreneurship in underserved communities. The students, participating in the NTU PEAK ASEAN Program, conducted field research and developed solutions for two main challenges: improving education access in underserved areas and creating mentorship programs for young entrepreneurs. The NTU PEAK ASEAN program is designed to develop leadership and problem-solving skills among its students through experiential learning in host countries in Southeast Asia and beyond. Participants create solutions for socio-economic issues while collaborating with local organizations. "Education is the cornerstone of sustainable development and transformative change," said Gabriel Tan, Chief Communications Officer of Prince Holding Group and Head of Prince Foundation. "By collaborating with NTU students, we are bridging nations and generations to tackle pressing challenges." The foundation, which serves as the philanthropic arm of Prince Holding Group, one of Cambodia's leading business groups, provided mentors to help students develop recommendations based on local needs while incorporating regional best practices. Desmond Woo, Deputy Director of NTU Singapore's Career and Attachment Office, said the Foundation gave students valuable experience addressing real-world problems. "The Foundation's guidance and resources have been instrumental in equipping students to deliver innovative, practical solutions that align with Cambodia's aspirations for growth and development," Woo said. The program aligns with the Cambodian government's development goals and reflects Prince Foundation's focus on education, healthcare and community service initiatives. This marks the second time Prince Foundation has hosted the NTU PEAK ASEAN Program in Cambodia, with the first time in 2022. Hashtag: #PrinceFoundation #NTU #EducationThe issuer is solely responsible for the content of this announcement.About Prince FoundationPrince Foundation, founded in 2015, is one of Cambodia's leading philanthropic foundations. A member of Prince Holding Group, one of the largest business groups in Cambodia, the Foundation works with local communities to build thriving living and working environments that elevate people's well-being and livelihoods, guided by the vision: "Together, Building a Better Future for Cambodia." Focusing on education and youth development, healthcare, and community engagement initiatives, Prince Foundation collaborates with partners to deliver sustainable programs that create opportunities for Cambodia's youth, build community resilience, and contribute to sustainable infrastructure. The Foundation's flagship projects include the Chen Zhi Scholarship, which offers full scholarships, stipends, internships, and job opportunities to 400 Cambodian university students over seven years, and Prince Horology, a state-of-the-art facility where aspiring Cambodian watchmakers learn the art of Swiss-style watchmaking. Since its inception, Prince Foundation has launched more than 250 philanthropic initiatives, benefiting over 1.5 million people and providing donations exceeding US$17 million.
SINGAPORE, Jan. 8, 2025 /PRNewswire/ -- Xnergy Autonomous Power Technologies (Xnergy) has secured a significant investment from Woori Venture Partners, a leading Korea-based VC fund. This move reinforces Woori Venture Partners' commitment to fostering cutting-edge technology in the rapidly evolving fields of new energy and mobility solutions, given Xnergy's advancements in high-power wireless charging for industrial robots and electric vehicles. (from left to right): Leading the charge for Xnergy are Dr Hu Xiaolei – Founder & Chief Technology Officer, Dr CF Tong, Founder & Chief Executive Officer and Mr Winston Koh – Founder & Chief Strategy Officer Established in 2018 in Singapore with a focus on emerging markets, Xnergy's products are sold in nearly 40 countries across Europe, America and Asia, with a strong pipeline of customers and partners including mobile robot companies, system integrators, and end users. Said Mr Alan Ang, Director of Woori Venture Partners: "We are excited to back Xnergy's ambition to be a global leader in wireless charging for new energy industries. We have invested globally into batteries, mobility and robotics startups and believe that Xnergy's breakthrough technology will be crucial in driving the next wave of sustainable growth in these industries. We look forward to working with Xnergy's best-in-class team to support its growth plans." Xnergy's product portfolio includes solutions tailored for both robots and vehicles: For mobile robots, Xnergy offers 3-9kW wireless non-contact charging systems, supporting on-demand trickle charging. For electric vehicles, Xnergy offers 22kW, 800V two-way charging and discharging solutions for fast and efficient energy management. The company's proprietary technology offers several advantages, including compact design, universal compatibility and highest power density. With a focus on scalability and customisation, Xnergy has introduced modular designs to meet varying customer needs while ensuring cost-effectiveness. The investment from Woori Venture Partners aligns with Xnergy's plans to expand into new sectors and regions, including new energy vehicles. Following prior investments from Hyundai Motor Group and Accuron Technologies (a subsidiary of Singapore's Temasek Holdings), this funding positions Xnergy to lead innovation in wireless charging solutions. Said Dr Hu Xiaolei, Chief Technology Officer of Xnergy: "This investment from Woori Venture Partners is a testament to the strength of our technology and potential to reshape autonomous electrified mobility. It provides us with the resources and strategic support needed to accelerate our expansion efforts. Together, we are not only advancing innovation but also ensuring that Xnergy continues to deliver cutting-edge solutions to meet the evolving demands of our customers worldwide." Xnergy has already deployed thousands of charging modules across more than 60 product categories from warehouse robots to ambulances, enabling over one million successful charging cycles globally. The company's strategic focus includes increasing charging power to 10kW and beyond, catering to the evolving needs of robots and electric vehicles. In addition to hardware, Xnergy offers advanced software solutions, including client and cloud platforms for monitoring charging performance. Customised charging curves for different batteries deliver faster charging times, while protecting battery life and maximising efficiency. With a team of experts from top-tier companies like ON Semiconductor, HP and Porsche, Xnergy is uniquely positioned to tackle the challenges of high-power wireless charging. The company continues to leverage its international expertise, with 80% of the team boasting global experience and over half holding advanced degrees. This partnership with Woori Venture Partners marks a significant milestone for Xnergy as it accelerates its growth trajectory, delivering next-generation wireless charging solutions to meet the demands of a rapidly transforming global market. About Xnergy Xnergy is the leading provider of high-power wireless charging solutions for all autonomous electrified mobility. Through its deployment-ready proprietary technology, it overcomes the limitations of traditional charging and enables a new way of power transmission – from electric vehicles to autonomous industrial robots. To date, thousands of modules have been deployed, effectively powering electrified mobility in nearly 40 countries. The company also sets the industry standard for wireless charging, building an ecosystem of end users, regulators, and manufacturers to establish the strong foundation required for widespread adoption. To learn more, visit xnergytech.com. About Woori Venture Partners Woori Venture Partners is South Korea's leading venture capital firm with a distinguished track record spanning over 40 years. Established in 1981, Woori Venture Partners has expanded its global presence with investment hubs in Silicon Valley, Shanghai and Singapore. With investments in over 2,000 companies, over 300 of which have successfully gone public, Woori Venture Partners is dedicated to driving innovation and fostering growth opportunities worldwide. Woori Venture Partners officially opened its Singapore office in 2023, and its presence in Southeast Asia reflects the growing investment opportunities in the region. Woori Venture Partners has: Cultivated a portfolio of close to 15 investments from Southeast Asia and India across diverse sectors including consumer, B2B, deep-tech and Web3 Partnered Arkana Ventures, an Indonesia-based VC firm with a successful track record of investing in Southeast Asia, to focus on building disruptive early-stage startups across Southeast Asia Collaborated with Saison Capital, the corporate venture capital arm of Credit Saison, to explore synergies on Web3 opportunities globally, with a particular focus on real-world assets and the intersection of financial services and blockchain
A12 藝術空間
ARM
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
